Colossal Biosciences spent more than a year building its GenoMorph AI platform, CEO and co-founder Ben Lamm told TechCrunch in October. The company combined developmental data from chickens, quail, ducks and pigeons with genetic information and 3D skull measurements from more than 70 bird species. The AI learns which regions of DNA are active as birds develop their beaks and facial structures, then predicts which genetic switches may have given the dodo its appearance.
Lamm said GenoMorph does not edit genes itself. It helps the team identify which genetic changes are worth investigating, and identifying a potential edit does not mean it is immediately introduced into an animal. The point, he said, is to make genetic engineering more precise, controlled and testable. So far the platform has identified approximately 2,300 promising DNA editing targets, which the company can now test in the lab.
This story is based on original reporting by Dominic-Madori Davis for TechCrunch. Read the full feature on TechCrunch → https://techcrunch.com/2026/10/14/colossal-biosciences-announces-new-ai-platform-to-help-accelerate-de-extinction-efforts/